ended of 30 June 2017 (Revised) Attention: Directors and Manager The Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results
reviewed by the authorized auditor of PricewaterhouseCooper ABAS Co.,Ltd. and approved by the Board of Directors of the Company on meeting No.3/2017 held on August 9, 2017 and also clarify the change of
Microsoft Word - MDA-EN-Apr2017-Jun2017-11Aug2017.doc 1 11 August 2017 Subject: Explanation of operating result in the financial statement ended 30 June 2017 To: Directors and Managers of the Stock
year. Dear Directors and Managers The Stock Exchange of Thailand, C.I.Group Public Company Limited hereby reports financial statements for the second quarter ended 30 June 2017 as follow; Revenue The
year. Dear Directors and Managers The Stock Exchange of Thailand, C.I.Group Public Company Limited hereby reports financial statements for the second quarter ended 30 June 2017 as follow; Revenue The
Limited (the “Company”) informed the Stock Exchange of Thailand on September 15, 2017 of the resolution of the Company’s board of directors approving the investment in digital hyper-reality attraction under
-86 -72 14 20% -76 -63 13 21% Administrative expenses -131 -105 26 25% -101 -79 22 28% Directors' s Remuneration -2 -2 0 10% -2 -2 0 0% Management's Remuneration -16 -12 4 30% -15 -11 4 36% Finance cost
1 10 November 2017 Subject: Explanation of operating result in the financial statement ended 30 September 2017 To: Directors and Managers of the Stock Exchange of Thailand With reference to the
year. Dear Directors and Managers The Stock Exchange of Thailand, C.I. Group Public Company Limited hereby reports financial statements for the third quarter ended 30 September 2017 as follow; Revenue
year. Dear Directors and Managers The Stock Exchange of Thailand, C.I. Group Public Company Limited hereby reports financial statements for the third quarter ended 30 September 2017 as follow; Revenue